Inhaled heparin: Past, present, and future

Zhewei Liu, Yuqing Ye, Ying Ma, Binjie Hu, Jesse Zhu

Research output: Journal PublicationReview articlepeer-review

Abstract

While heparin has traditionally served as a key anticoagulant in clinical practice for nearly a century, recent years have witnessed a growing interest in its role as a potent antiinflammatory and antiviral agent, as well as an anticancer agent. To address challenges with injection-based delivery, exploring patient-friendly routes such as oral and pulmonary delivery is crucial. This review specifically highlights the multiple therapeutic benefits of inhaled heparin. In summary, this review serves as a valuable source of information, providing deep insights into the diverse therapeutic advantages of inhaled heparin and its potential applications within clinical contexts.

Original languageEnglish
Article number104065
JournalDrug Discovery Today
Volume29
Issue number8
DOIs
Publication statusPublished - Aug 2024

Keywords

  • anticancer
  • antiinflammatory
  • antiviral
  • heparin
  • pulmonary delivery

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Inhaled heparin: Past, present, and future'. Together they form a unique fingerprint.

Cite this